Cargando…
Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
BACKGROUND: Improving the safety of subcutaneous immunotherapy (SCIT) for food allergy is necessary to reduce side effects and achieve long-term tolerance. We determined the effect of dietary supplementation with 1% non-digestible short- and long-chain fructo-oligosaccharides (scFOS/lcFOS) on safety...
Autores principales: | Wagenaar, Laura, van Roest, Manon, Kruijssen, Laura J. W., Simons, Peter J., Boon, Louis, Vonk, Marlotte M., van Esch, Betty C. A. M., Knippels, Leon M. J., Garssen, Johan, Pieters, Raymond H. H., Smit, Joost J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448225/ https://www.ncbi.nlm.nih.gov/pubmed/30988664 http://dx.doi.org/10.1186/s12948-019-0111-5 |
Ejemplares similares
-
Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model
por: Wagenaar, Laura, et al.
Publicado: (2018) -
Supplementation With 2′-FL and scGOS/lcFOS Ameliorates Rotavirus-Induced Diarrhea in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2018) -
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017) -
Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
por: Vonk, Marlotte M., et al.
Publicado: (2017) -
Looking for Possible Benefits of Combining Short-Chain Fructo-Oligosaccharides (scFOS) with Saccharomyces cerevisiae Sc 47 on Weaned Pigs Orally Challenged with Escherichia coli F4(+)
por: Ferreres-Serafini, Laia, et al.
Publicado: (2023)